Clinical trials: Retinal Neovascularization, Unspecified

Conjunctivitis, Glaucoma

Feasibility Study and Preliminary Application Study on Iris OCTA

• Unknown status
• Age: All ages
• Observational study

All participants will underwent imaging using the OCTA system (Zeiss) with the anterior segment optical adaptor lens. The main outcomes are iris blood flow density and vascular density.

Conditions

Conjunctivitis, Glaucoma, Myopia, Diabetic Retinopathy

Trial name

NCT03631108

Testing

OCTA (ZEISS)

Volunteers

4,000 people, healthy volunteers welcome

Sponsor

Shanghai Eye Disease Prevention and Treatment Center